These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35126876)

  • 1. Effect of an antiviral drug control and its variable order fractional network in host COVID-19 kinetics.
    Wang B; Mondal J; Samui P; Chatterjee AN; Yusuf A
    Eur Phys J Spec Top; 2022; 231(10):1915-1929. PubMed ID: 35126876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fractional-order differential equation model of COVID-19 infection of epithelial cells.
    Chatterjee AN; Ahmad B
    Chaos Solitons Fractals; 2021 Jun; 147():110952. PubMed ID: 33967407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection with lytic and non-lytic immune responses: A fractional order optimal control theoretical study.
    Chatterjee AN; Basir FA; Almuqrin MA; Mondal J; Khan I
    Results Phys; 2021 Jul; 26():104260. PubMed ID: 34055582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hybrid fractional optimal control for a novel Coronavirus (2019-nCov) mathematical model.
    Sweilam NH; Al-Mekhlafi SM; Baleanu D
    J Adv Res; 2021 Sep; 32():149-160. PubMed ID: 32864171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of fractional optimal control theory for the mitigating of novel coronavirus in Algeria.
    El Hadj Moussa Y; Boudaoui A; Ullah S; Muzammil K; Riaz MB
    Results Phys; 2022 Aug; 39():105651. PubMed ID: 35668848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional optimal control problem for an age-structured model of COVID-19 transmission.
    Khajji B; Kouidere A; Elhia M; Balatif O; Rachik M
    Chaos Solitons Fractals; 2021 Feb; 143():110625. PubMed ID: 33519119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the effects of preventive measures and vaccination on the COVID-19 spread in Benin Republic with optimal control.
    Agossou O; Atchadé MN; Djibril AM
    Results Phys; 2021 Dec; 31():104969. PubMed ID: 34804781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effects of 2-DG drug restraining SARS-CoV-2 infection: A fractional order optimal control study.
    Samui P; Mondal J; Ahmad B; Chatterjee AN
    J Biol Phys; 2022 Dec; 48(4):415-438. PubMed ID: 36459249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal control approach of a mathematical modeling with multiple delays of the negative impact of delays in applying preventive precautions against the spread of the COVID-19 pandemic with a case study of Brazil and cost-effectiveness.
    Kouidere A; Kada D; Balatif O; Rachik M; Naim M
    Chaos Solitons Fractals; 2021 Jan; 142():110438. PubMed ID: 33519112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China.
    Cao Y; Cai K; Xiong L
    Acta Virol; 2020; 64(2):245-250. PubMed ID: 32551792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within Host Dynamics of SARS-CoV-2 in Humans: Modeling Immune Responses and Antiviral Treatments.
    Ghosh I
    SN Comput Sci; 2021; 2(6):482. PubMed ID: 34661166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modeling of the spread of COVID-19 among different age groups in Morocco: Optimal control approach for intervention strategies.
    Kada D; Kouidere A; Balatif O; Rachik M; Labriji EH
    Chaos Solitons Fractals; 2020 Dec; 141():110437. PubMed ID: 33519111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modelling and optimal cost-effective control of COVID-19 transmission dynamics.
    Olaniyi S; Obabiyi OS; Okosun KO; Oladipo AT; Adewale SO
    Eur Phys J Plus; 2020; 135(11):938. PubMed ID: 33262923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.
    Sanguedolce F; Zanelli M; Froio E; Bisagni A; Zizzo M; Ascani S; Stallone G; Netti S; Ranieri E; Falagario U; Carrieri G; Cormio L
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):563-575. PubMed ID: 34236278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal control strategies for the transmission risk of COVID-19.
    Lemecha Obsu L; Feyissa Balcha S
    J Biol Dyn; 2020 Dec; 14(1):590-607. PubMed ID: 32696723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
    Zhang L; Dong L; Ming L; Wei M; Li J; Hu R; Yang J
    BMC Pregnancy Childbirth; 2020 Jul; 20(1):394. PubMed ID: 32641013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fractional order approach to modeling and simulations of the novel COVID-19.
    Owusu-Mensah I; Akinyemi L; Oduro B; Iyiola OS
    Adv Differ Equ; 2020; 2020(1):683. PubMed ID: 33288983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal control for COVID-19 pandemic with quarantine and antiviral therapy.
    Masud MAB; Ahmed M; Rahman MH
    Sens Int; 2021; 2():100131. PubMed ID: 34766063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.